Human salivary microRNAs in Cancer
- PMID: 29556321
- PMCID: PMC5858485
- DOI: 10.7150/jca.21180
Human salivary microRNAs in Cancer
Abstract
Circulating microRNAs (miRNAs) have emerged as excellent candidates for cancer biomarkers. Several recent studies have highlighted the potential use of saliva for the identification of miRNAs as novel biomarkers, which represents a great opportunity to improve diagnosis and monitor general health and disease. This review summarises the mechanisms of miRNAs deregulation in cancer, the value of targeting them with a therapeutic intention and the evidence of the potential clinical use of miRNAs expressed in saliva for the detection of different cancer types. We also provide a comprehensive review of the different methods for normalising the levels of specific miRNAs present in saliva, as this is a critical step in their analysis, and the challenge to validate salivary miRNAs as a reality to manage cancer patients.
Keywords: biomarkers; cancer; liquid biopsy; miRNAs; normalization; saliva.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.BMC Cancer. 2019 Aug 28;19(1):843. doi: 10.1186/s12885-019-6037-y. BMC Cancer. 2019. PMID: 31455274 Free PMC article.
-
Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.Med Res Rev. 2012 Mar;32(2):326-48. doi: 10.1002/med.20215. Epub 2010 Nov 9. Med Res Rev. 2012. PMID: 22383180 Review.
-
The Potential Use of Salivary miRNAs as Promising Biomarkers for Detection of Cancer: A Meta-Analysis.PLoS One. 2016 Nov 10;11(11):e0166303. doi: 10.1371/journal.pone.0166303. eCollection 2016. PLoS One. 2016. PMID: 27832115 Free PMC article.
-
A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.J Clin Med. 2019 Nov 20;8(12):2029. doi: 10.3390/jcm8122029. J Clin Med. 2019. PMID: 31757017 Free PMC article.
-
Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives.Front Physiol. 2019 Dec 10;10:1476. doi: 10.3389/fphys.2019.01476. eCollection 2019. Front Physiol. 2019. PMID: 31920689 Free PMC article. Review.
Cited by
-
MicroRNA‑363‑3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage.Mol Med Rep. 2019 Feb;19(2):935-942. doi: 10.3892/mmr.2018.9711. Epub 2018 Nov 29. Mol Med Rep. 2019. PMID: 30535489 Free PMC article.
-
Diagnostic and therapeutic biomarkers in colorectal cancer: a review.Am J Cancer Res. 2022 Feb 15;12(2):661-680. eCollection 2022. Am J Cancer Res. 2022. PMID: 35261794 Free PMC article. Review.
-
Extracellular miRNAs as Biomarkers of Head and Neck Cancer Progression and Metastasis.Int J Mol Sci. 2019 Sep 27;20(19):4799. doi: 10.3390/ijms20194799. Int J Mol Sci. 2019. PMID: 31569614 Free PMC article. Review.
-
Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review.Int J Mol Sci. 2020 Jan 30;21(3):907. doi: 10.3390/ijms21030907. Int J Mol Sci. 2020. PMID: 32019170 Free PMC article.
-
Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review.Maxillofac Plast Reconstr Surg. 2021 Jun 30;43(1):19. doi: 10.1186/s40902-021-00303-9. Maxillofac Plast Reconstr Surg. 2021. PMID: 34191144 Free PMC article. Review.
References
-
- Kishore L, Kaur N, Singh R. Distinct biomarkers for early diagnosis of diabetic nephropathy. Curr Diabetes Rev. 2017;13(6):598–605. [Epub ahead of print] - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources